nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012
|
Thuler, Luiz Claudio Santos |
|
2016 |
96 |
3 |
p. 355-362 |
artikel |
2 |
BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients
|
Gilli, Stefanie |
|
2016 |
96 |
3 |
p. 421-429 |
artikel |
3 |
Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations
|
Lekovic, Danijela |
|
2016 |
96 |
3 |
p. 393-404 |
artikel |
4 |
Bortezomib-containing regimens (BCR) for the treatment of non-transplant eligible multiple myeloma
|
Jimenez-Zepeda, Victor H |
|
2017 |
96 |
3 |
p. 431-439 |
artikel |
5 |
Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy
|
Dlouhy, Ivan |
|
2016 |
96 |
3 |
p. 405-410 |
artikel |
6 |
Cold agglutinin disease complicated by acrocyanosis and necrosis
|
Gregory, Gareth P. |
|
2017 |
96 |
3 |
p. 509-510 |
artikel |
7 |
Comparison of engraftment following different stem cell mobilization modalities in patients with multiple myeloma treated with a uniform induction regimen containing bortezomib, cyclophosphamide and dexamethasone
|
Benyamini, Noam |
|
2016 |
96 |
3 |
p. 461-467 |
artikel |
8 |
Cyclin A2 as a potential differential marker of splenic diffuse red pulp small B-cell lymphoma: a report of the first case
|
Ben Younes, Khaoula |
|
2016 |
96 |
3 |
p. 511-512 |
artikel |
9 |
Evidence for a role of decitabine in the treatment of myeloid sarcoma
|
Gornicec, Max |
|
2016 |
96 |
3 |
p. 505-506 |
artikel |
10 |
Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause
|
Gebhart, Johanna |
|
2016 |
96 |
3 |
p. 489-495 |
artikel |
11 |
Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?
|
Paubelle, Etienne |
|
2016 |
96 |
3 |
p. 363-371 |
artikel |
12 |
GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling
|
Koch, Corinna |
|
2016 |
96 |
3 |
p. 345-353 |
artikel |
13 |
Improved clinical outcomes for multiple myeloma patients treated at a single specialty clinic
|
Berenson, Ariana |
|
2016 |
96 |
3 |
p. 441-448 |
artikel |
14 |
Intravascular lymphoma: look through the small vessels
|
Prats-Martín, Concepción |
|
2016 |
96 |
3 |
p. 517-519 |
artikel |
15 |
JAK2V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohort
|
Ianotto, Jean-Christophe |
|
2016 |
96 |
3 |
p. 383-386 |
artikel |
16 |
Late isolated intraocular relapse of a systemic diffuse large B-cell lymphoma detected by flow cytometry
|
Sarrate, Edurne |
|
2016 |
96 |
3 |
p. 523-524 |
artikel |
17 |
Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8
|
Konuma, Takaaki |
|
2017 |
96 |
3 |
p. 469-478 |
artikel |
18 |
Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib
|
Berenson, Ariana |
|
2016 |
96 |
3 |
p. 449-459 |
artikel |
19 |
Polymorphisms of the TGF-β1 gene and the risk of acquired aplastic anemia in a Chinese population
|
Liang, Xue-hong |
|
2016 |
96 |
3 |
p. 339-344 |
artikel |
20 |
Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome
|
Behnia, Fatemeh |
|
2016 |
96 |
3 |
p. 497-500 |
artikel |
21 |
Presence of risk factors does not affect outcome in early stage pediatric Hodgkin lymphoma treated with ABVD
|
Bhethanabhotla, Sainath |
|
2016 |
96 |
3 |
p. 521-522 |
artikel |
22 |
Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment
|
Kitahara, Hideaki |
|
2016 |
96 |
3 |
p. 411-420 |
artikel |
23 |
Radiologic and molecular remission of follicular T cell lymphoma treated with lenalidomide
|
Kwong, Yok-Lam |
|
2016 |
96 |
3 |
p. 513-515 |
artikel |
24 |
Real world epidemiology of myeloproliferative neoplasms: a population based study in Korea 2004–2013
|
Byun, Ja Min |
|
2016 |
96 |
3 |
p. 373-381 |
artikel |
25 |
Reversion of serum VZV-IgG antibody preceding disseminated visceral varicella zoster after hematopoietic stem cell transplantation
|
Arakawa, Sayaka |
|
2016 |
96 |
3 |
p. 529-530 |
artikel |
26 |
Reversion of serum VZV-IgG antibody preceding disseminated visceral varicella zoster after hematopoietic stem cell transplantation
|
Arakawa, Sayaka |
|
|
96 |
3 |
p. 529-530 |
artikel |
27 |
Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence
|
Ong, Shin Yeu |
|
2016 |
96 |
3 |
p. 525-527 |
artikel |
28 |
Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy
|
Gong, Zimu |
|
2016 |
96 |
3 |
p. 501-504 |
artikel |
29 |
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN
|
Breccia, Massimo |
|
2016 |
96 |
3 |
p. 387-391 |
artikel |
30 |
Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center
|
González, Karla Javier |
|
2016 |
96 |
3 |
p. 507-508 |
artikel |
31 |
Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML
|
Holtick, Udo |
|
2016 |
96 |
3 |
p. 479-487 |
artikel |